175 related articles for article (PubMed ID: 26170975)
1. Lugol chromoendoscopic screening for esophageal dysplasia/early squamous cell carcinoma in patients with esophageal symptoms in low-risk region in China.
Shao Y; Yu ZL; Ji M; Wu YD; Yu YZ; Liang XM; Yu LI; Niu YL; Li P; Zhang ST
Oncol Lett; 2015 Jul; 10(1):45-50. PubMed ID: 26170975
[TBL] [Abstract][Full Text] [Related]
2. Pre-procedure oral administration of pronase improves efficacy of lugol chromoendoscopy in esophageal squamous cell carcinoma screening: a prospective, double-blinded, randomized, controlled trial.
Zhao X; Guo M; Zhu S; Zhang L; Dong T; Luo H; Yu W; Zhu J; Fan X; Han Y; Liu Z
Surg Endosc; 2023 Jun; 37(6):4421-4430. PubMed ID: 36781469
[TBL] [Abstract][Full Text] [Related]
3. Lugol Chromoendoscopy Detects Esophageal Dysplasia With Low Levels of Sensitivity in a High-Risk Region of China.
Li J; Xu R; Liu M; Cai H; Cao C; Liu F; Li F; Guo C; Pan Y; He Z; Ke Y
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1585-1592. PubMed ID: 29174712
[TBL] [Abstract][Full Text] [Related]
4. Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic achalasia.
Ponds FA; Moonen A; Smout AJPM; Rohof WOA; Tack J; van Gool S; Bisschops R; Bredenoord AJ; Boeckxstaens GE
Am J Gastroenterol; 2018 Jun; 113(6):855-862. PubMed ID: 29748564
[TBL] [Abstract][Full Text] [Related]
5. Narrow-band imaging vs Lugol chromoendoscopy in screening for esophageal squamous cell neoplasia: a randomized trial.
Chaber-Ciopinska A; Kiprian D; Wieszczy P; Bielasik A; Bugajski M; Januszewicz W; Jarzabski A; Niemiec M; Mroz A; Kawecki A; Regula J; Kaminski MF
Pol Arch Intern Med; 2023 Oct; 133(10):. PubMed ID: 36916462
[TBL] [Abstract][Full Text] [Related]
6. Lugol chromoendoscopy as a diagnostic tool in so-called endoscopy-negative GERD.
Yoshikawa I; Yamasaki M; Yamasaki T; Kume K; Otsuki M
Gastrointest Endosc; 2005 Nov; 62(5):698-703; quiz 752, 754. PubMed ID: 16246682
[TBL] [Abstract][Full Text] [Related]
7. Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma.
Boller D; Spieler P; Schoenegg R; Neuweiler J; Kradolfer D; Studer R; Grossenbacher R; Zuercher U; Meyenberger C; Borovicka J
Surg Endosc; 2009 Dec; 23(12):2748-54. PubMed ID: 19444514
[TBL] [Abstract][Full Text] [Related]
8. Evaluating synchronous esophageal cancer in head and neck cancer patients using Lugol dye chromoendoscopy.
Laohawiriyakamol S; Sunpaweravong S; Leelamanit V; Pruegsanusak K; Sinkijcharoenchai W
J Med Assoc Thai; 2014 Nov; 97(11):1164-70. PubMed ID: 25675681
[TBL] [Abstract][Full Text] [Related]
9. Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus.
Fagundes RB; de Barros SG; Pütten AC; Mello ES; Wagner M; Bassi LA; Bombassaro MA; Gobbi D; Souto EB
Endoscopy; 1999 May; 31(4):281-5. PubMed ID: 10376452
[TBL] [Abstract][Full Text] [Related]
10. Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial.
Gruner M; Denis A; Masliah C; Amil M; Metivier-Cesbron E; Luet D; Kaasis M; Coron E; Le Rhun M; Lecleire S; Antonietti M; Legoux JL; Lefrou L; Renkes P; Tarreirias AL; Balian P; Rey P; Prost B; Cellier C; Rahmi G; Samaha E; Fratte S; Guerrier B; Landel V; Touzet S; Ponchon T; Pioche M
Endoscopy; 2021 Jul; 53(7):674-682. PubMed ID: 32698233
[TBL] [Abstract][Full Text] [Related]
11. Delineating the extent of esophageal squamous cell carcinoma.
Kono M; Kanesaka T; Ishihara R; Kitamura M; Shoji A; Inoue T; Matsueda K; Miyake M; Waki K; Shimamoto Y; Fukuda H; Iwagami H; Matsuura N; Nakahira H; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Nakatsuka SI; Fujiwara Y
Esophagus; 2021 Oct; 18(4):790-796. PubMed ID: 34052934
[TBL] [Abstract][Full Text] [Related]
12. Fujinon intelligent color enhancement for the diagnosis of early esophageal squamous cell carcinoma and precancerous lesion.
Li YX; Shen L; Yu HG; Luo HS; Yu JP
Turk J Gastroenterol; 2014 Aug; 25(4):365-9. PubMed ID: 25254516
[TBL] [Abstract][Full Text] [Related]
13. Narrow band imaging with magnification can pick up esophageal squamous cell carcinoma more efficiently than lugol chromoendoscopy in patients after chemoradiotherapy.
Asada-Hirayama I; Kodashima S; Fujishiro M; Ono S; Niimi K; Mochizuki S; Konno-Shimizu M; Mikami-Matsuda R; Minatsuki C; Nakayama C; Takahashi Y; Yamamichi N; Koike K
Diagn Ther Endosc; 2013; 2013():256439. PubMed ID: 23476110
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers.
Dubuc J; Legoux J-; Winnock M; Seyrig J-; Barbier J-; Barrioz T; Laugier R; Boulay G; Grasset D; Sautereau D; Grigoresco D; Butel J; Scoazec J-; Ponchon T;
Endoscopy; 2006 Jul; 38(7):690-5. PubMed ID: 16874909
[TBL] [Abstract][Full Text] [Related]
15. Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis.
Bugter O; van de Ven SEM; Hardillo JA; Bruno MJ; Koch AD; Baatenburg de Jong RJ
Head Neck; 2019 Apr; 41(4):1122-1130. PubMed ID: 30593712
[TBL] [Abstract][Full Text] [Related]
16. Tolerability of magnifying narrow band imaging endoscopy for esophageal cancer screening.
Yamasaki Y; Takenaka R; Hori K; Takemoto K; Kawano S; Kawahara Y; Okada H; Fujiki S; Yamamoto K
World J Gastroenterol; 2015 Mar; 21(9):2793-9. PubMed ID: 25759551
[TBL] [Abstract][Full Text] [Related]
17. Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis.
Morita FH; Bernardo WM; Ide E; Rocha RS; Aquino JC; Minata MK; Yamazaki K; Marques SB; Sakai P; de Moura EG
BMC Cancer; 2017 Jan; 17(1):54. PubMed ID: 28086818
[TBL] [Abstract][Full Text] [Related]
18. Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.
Liu M; Liu Z; Liu F; Guo C; Xu R; Li F; Liu A; Yang H; Zhang S; Shen L; Duan L; Wu Q; Cao C; Pan Y; Liu Y; Li J; Cai H; He Z; Ke Y
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1626-1635.e7. PubMed ID: 31518715
[TBL] [Abstract][Full Text] [Related]
19. LUGOL'S IODINE CHROMOENDOSCOPY VERSUS NARROW BAND IMAGE ENHANCED ENDOSCOPY FOR THE DETECTION OF ESOPHAGEAL CANCER IN PATIENTS WITH STENOSIS SECONDARY TO CAUSTIC/CORROSIVE AGENT INGESTION.
Pennachi CMPS; Moura DTH; Amorim RBP; Guedes HG; Kumbhari V; Moura EGH
Arq Gastroenterol; 2017; 54(3):250-254. PubMed ID: 28492712
[TBL] [Abstract][Full Text] [Related]
20. Lugol chromo-endoscopy versus narrow band imaging for endoscopic screening of esophageal squamous-cell carcinoma in patients with a history of cured esophageal cancer: a feasibility study.
Lecleire S; Antonietti M; Iwanicki-Caron I; Duclos A; Lemoine F; Pessot FL; Michel P; Ducrotté P; Di Fiore F
Dis Esophagus; 2011 Aug; 24(6):418-22. PubMed ID: 21309914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
